Sonic Healthcare LimitedShs Aktie
17,07EUR | 0,11EUR | 0,67% |
WKN: 909081 / ISIN: AU000000SHL7
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 95,02 |
State Street Global Advisors, Australia, Ltd. | 3,76 |
Michael D. Boyd | 3,15 |
BlackRock Fund Advisors | 2,92 |
Guinness Asset Mgmt. Fund Plc - Global Equity Income Fund | 2,00 |
Government Pension Fund - Global (The) | 1,69 |
Vanguard Australian Shares Index Fund | 1,52 |
Vanguard Total International Stock Index Fund | 1,39 |
Netwealth Investments Ltd. | 1,07 |
BlackRock Investment Management (Australia) Ltd. | 1,06 |
State Street Global Advisors Trust Co. | 1,03 |
BlackRock Investment Management (UK) Ltd. | 0,86 |
Vanguard Developed Markets Index Fund | 0,85 |
Argo Investments Ltd. (Investment Management) | 0,78 |
Commonwealth Superannuation Corp. (Investment Management) | 0,72 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 37 000 | 38 000 | 41 000 | 41 000 | 43 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,18 | 0,24 | 0,23 | 0,19 | 0,20 |
Bilanz (in Mio. AUD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 2 455 | 2 285 | 2 306 | 2 133 | 2 353 |
Summe Anlagevermögen | 10 176 | 9 985 | 10 802 | 11 428 | 13 038 |
Summe Aktiva | 12 631 | 12 270 | 13 108 | 13 561 | 15 391 |
Bilanz (in Mio. AUD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 4 616 | 3 235 | 3 013 | 3 100 | 4 515 |
Summe Fremdkapital | 6 967 | 5 765 | 5 679 | 5 639 | 7 316 |
Summe Eigenkapital | 5 664 | 6 504 | 7 428 | 7 922 | 8 075 |
Summe Passiva | 12 631 | 12 270 | 13 108 | 13 561 | 15 391 |
Adresse
Grosvenor Place, 2000 Sydney | |
Telefon | +61 (2) 9855-5444 |
Internet | https://www.sonichealthcare.com/ |
Management
Christine Bennett
Independent Non-Executive Director |
Christopher David Wilks
CFO, Finance Director & Executive Director |
Colin Stephen Goldschmidt
Chief Executive Officer, MD & Executive Director |
Katharine Giles
Independent Non-Executive Director |
Kathryn Dianne Spargo
Independent Non-Executive Director |
Louis James Panaccio
Independent Non-Executive Director |
Mark R. Compton
Chairman |
Neville J. Mitchell
Independent Non-Executive Director |
Paul Joseph Alexander
Secretary & Deputy Chief Financial Officer |
Peter Joseph
Chief Information Officer |
Stephen Fairy
Group Chief Medical Officer |
Suzanne Crowe
Independent Non-Executive Director |